These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21125964)
1. Quality management benchmarking: FDA compliance in pharmaceutical industry. Jochem R; Landgraf K Int J Health Care Qual Assur; 2010; 23(8):690-8. PubMed ID: 21125964 [TBL] [Abstract][Full Text] [Related]
2. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321 [TBL] [Abstract][Full Text] [Related]
4. International benchmarking and best practice management: in search of health care and hospital excellence. von Eiff W Adv Health Care Manag; 2015; 17():223-52. PubMed ID: 25985514 [TBL] [Abstract][Full Text] [Related]
5. The critical phase inspection process: a benchmarking study in search of industries' best practices. Herman DR; Dangler TL; Houser DA; Lewis TG; Masten JL; Taylor IE Qual Assur; 1993; 2(1-2):186-90. PubMed ID: 8156211 [TBL] [Abstract][Full Text] [Related]
6. Effective executive management in the pharmaceutical industry. Tran H; Kleiner BH J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973 [TBL] [Abstract][Full Text] [Related]
7. Schering-Plough agrees to pay FDA $500 million and bring factories into compliance. Kuehn BM J Am Vet Med Assoc; 2002 Jul; 221(2):174, 180. PubMed ID: 12118571 [No Abstract] [Full Text] [Related]
8. [The role of benchmarking seen from the perspective of the Federal Joint Committee (G-BA)]. Siebig J Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):408-11. PubMed ID: 21767803 [TBL] [Abstract][Full Text] [Related]
11. Corporate compliance programs for FDA-regulated companies: incentives for their development and the impact of the federal sentencing guidelines for organizations. Freyer DH Food Drug Law J; 1996; 51(2):225-42. PubMed ID: 11820200 [No Abstract] [Full Text] [Related]
12. [An analysis of the pharmaceuticals market in Vietnam]. Simonet D Sante; 2001; 11(3):155-60. PubMed ID: 11641078 [TBL] [Abstract][Full Text] [Related]
14. The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals. Cairns A; Yarker YE Curr Med Res Opin; 2008 May; 24(5):1371-8. PubMed ID: 18384708 [TBL] [Abstract][Full Text] [Related]
15. Infusion alliances: benchmarking and data collection. Poole S J Infus Nurs; 2010; 33(5):310-5. PubMed ID: 20841985 [TBL] [Abstract][Full Text] [Related]
16. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations? Hewitt NJ; de Kanter R; LeCluyse E Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835 [TBL] [Abstract][Full Text] [Related]
17. Hospital benchmarking: are U.S. eye hospitals ready? de Korne DF; van Wijngaarden JD; Sol KJ; Betz R; Thomas RC; Schein OD; Klazinga NS Health Care Manage Rev; 2012; 37(2):187-98. PubMed ID: 21799431 [TBL] [Abstract][Full Text] [Related]
18. Six Sigma: not for the faint of heart. Benedetto AR Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564 [TBL] [Abstract][Full Text] [Related]
20. Preparing for an FDA preapproval inspection. Blackmer RA Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]